COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study

Introduction: Data on lymphoma patients with SARS-CoV-2 infection (COVID-19) are lacking. A large cancer cohort study showed that number of comorbidities, active cancer, and worse performance status were associated with increased 30-day mortality (Kuderer 2020). Variables contributing to risk of poo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ip, Andrew, Mato, Anthony, Intrator, Jordan, Howard, Nicholas P, Petrillo, Alessandra, Vicioso, Rosalba, Sebti, Rani, Cicogna, Cristina, Magarelli, Gabriella, Leslie, Lori A., Goy, Andre H., Feldman, Tatyana A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2020
Materias:
905.Outcomes Research-Malignant Conditions (Lymphoid Disease)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330210/
http://dx.doi.org/10.1182/blood-2020-141871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330210/
http://dx.doi.org/10.1182/blood-2020-141871

Ejemplares similares